Smart Immune
Pioneering thymus-empowered T-cell platform to fight cancer and infection
📍 Paris, Île-de-France
Stats
- Employees (LinkedIn)
- 38
- Size bucket
- 11-50 employees
- Followers
- 5486
- Founded
- 2017
- Org type
- Privately Held
- Country
- FR
- LinkedIn ID
- 29355721
- Slug
- smartimmune
Industries
Specialties
About
Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.
Locations (1)
- Paris Biotech santé - Pole innovation 29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR